Crohn's disease patients under combined therapy with Azathioprine and Infliximab present persistent inflammation together with a counter regulatory response during clinical disease remission

Advanced search

Search - Use quotation marks to get a more specific result

Index

Field of knowledge

Start date

Betweenand

Full text
Author(s):	Duarte-Silva, M. ; Parra, R. S. ; Feitosa, M. R. ; Feres, O. ; Ribeiro da Rocha, J. J. ; Cardoso, C. R. D. B. Total Authors: 6
Document type:	Journal article
Source:	JOURNAL OF CROHNS & COLITIS; v. 13, p. 2-pg., 2019-03-01.

FAPESP's process:	17/08651-1 - Immunomodulatory effects of dehidroepiandrosterone (DHEA) in the immune response of Crohn's disease patients refractory to anti-TNF treatment
Grantee:	Cristina Ribeiro de Barros Cardoso
Support Opportunities:	Regular Research Grants